Adjunctive vagus nerve stimulation for treatment-resistant depression: a preliminary study
Zhang X, Guo YM, Ning YP, Cao LP, Rao YH, Sun JQ, Qing MJ, Zheng W
International Journal of Psychiatry in Clinical Practice · 2022
Key finding
After 3 months of treatment with VNS, the antidepressant response and remission rates were 42.9% and 28.6%, respectively.
- Condition
- Depression
- Stimulation
- iVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Cite this study
Zhang, X., Guo, Y. M., Ning, Y. P., Cao, L. P., Rao, Y. H., Sun, J. Q., Qing, M. J., & Zheng, W. (2022). Adjunctive vagus nerve stimulation for treatment-resistant depression: a preliminary study. International Journal of Psychiatry in Clinical Practice, 26(4), 337-342. https://doi.org/10.1080/13651501.2021.2019789
Related studies in Depression
Long-term efficacy and safety of vagus nerve stimulation in treatment-resistant depression: A systematic review
Rosson et al. · Journal of Affective Disorders · 2026 · Systematic Review / Meta-Analysis
The efficacy and safety of transcutaneous auricular vagus nerve stimulation in the treatment of depressive disorder: a systematic review and meta-analysis of randomized controlled trials
Tan et al. · Journal of Affective Disorders · 2023 · Systematic Review / Meta-Analysis
Adjunctive Vagus Nerve Stimulation for Treatment-Resistant Depression: a Quantitative Analysis
Zhang et al. · The Psychiatric quarterly · 2020 · Systematic Review / Meta-Analysis
Vagus Nerve Stimulation for Depression: A Systematic Review
Lv et al. · Frontiers in psychology · 2019 · Systematic Review / Meta-Analysis
Summary by Vagus Research. Always consult the primary source for the authoritative record.